These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34837558)

  • 1. Effect of combined treatment with lobaplatin and osthole on inducing apoptosis and inhibiting proliferation in human breast cancer MDA-MB-231 cells.
    Liu N; Tian H; Zhang G; Sun N; Wang S
    Med Oncol; 2021 Nov; 39(1):16. PubMed ID: 34837558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lobaplatin as a single agent and in combination with TRAIL on the growth of triple-negative p53-mutated breast cancers in vitro.
    Engel JB; Martens T; Hahne JC; Häusler SF; Krockenberger M; Segerer S; Djakovic A; Meyer S; Dietl J; Wischhusen J; Honig A
    Anticancer Drugs; 2012 Apr; 23(4):426-36. PubMed ID: 22314264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lobaplatin inhibits growth of gastric cancer cells by inducing apoptosis.
    Yin CY; Lin XL; Tian L; Ye M; Yang XY; Xiao XY
    World J Gastroenterol; 2014 Dec; 20(46):17426-33. PubMed ID: 25516654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lobaplatin inhibits breast cancer progression, cell proliferation while it induces cell apoptosis by downregulating MTDH expression.
    Tian W; Hao S; Gao B; Jiang Y; Zhang X; Zhang S; Guo L; Zhao J; Zhang G; Chen Y; Li Z; Luo D
    Drug Des Devel Ther; 2018; 12():3563-3571. PubMed ID: 30464390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE.
    Wang Z; Tang X; Zhang Y; Qi R; Li Z; Zhang K; Liu Z; Yang X
    Biomed Pharmacother; 2012 Apr; 66(3):161-6. PubMed ID: 22425181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lobaplatin suppresses proliferation and induces apoptosis in the human colorectal carcinoma cell Line LOVO in vitro.
    Dai HY; Liu L; Qin SK; He XM; Li SY
    Biomed Pharmacother; 2011 Jun; 65(3):137-41. PubMed ID: 21612887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antitumor effect of lobaplatin against Ishikawa endometrial cancer cells in vitro and in vivo.
    He J; Zhang H
    Biomed Pharmacother; 2019 Jun; 114():108762. PubMed ID: 30925454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of Lobaplatin against esophageal squamous cell carcinoma through caspase-dependent apoptosis and increasing the Bax/Bcl-2 ratio.
    Du L; Fei Z; Song S; Wei N
    Biomed Pharmacother; 2017 Nov; 95():447-452. PubMed ID: 28865364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lobaplatin arrests cell cycle progression, induces apoptosis and alters the proteome in human cervical cancer cell Line CaSki.
    Li X; Ran L; Fang W; Wang D
    Biomed Pharmacother; 2014 Apr; 68(3):291-7. PubMed ID: 24239273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lobaplatin arrests cell cycle progression, induces apoptosis and impairs migration and invasion in B16-F10 melanoma cell line in vitro.
    Yang F; Yu Y; Lei Q; Zeng A; Li Y; Xie Y; Ye T; Wei Y
    Biomed Pharmacother; 2015 Feb; 69():402-8. PubMed ID: 25661389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lobaplatin induces BGC-823 human gastric carcinoma cell apoptosis via ROS- mitochondrial apoptotic pathway and impairs cell migration and invasion.
    Li Y; Liu B; Yang F; Yu Y; Zeng A; Ye T; Yin W; Xie Y; Fu Z; Zhao C
    Biomed Pharmacother; 2016 Oct; 83():1239-1246. PubMed ID: 27565846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer Mechanism of Lobaplatin as Monotherapy and in Combination with Paclitaxel in Human Gastric Cancer.
    Hua S; Kong X; Chen B; Zhuang W; Sun Q; Yang W; Liu W; Zhang Y
    Curr Mol Pharmacol; 2018; 11(4):316-325. PubMed ID: 30101722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of lobaplatin alone or in combination with antitubulin agents in non-small-cell lung cancer.
    Xie CY; Xu YP; Jin W; Lou LG
    Anticancer Drugs; 2012 Aug; 23(7):698-705. PubMed ID: 22441567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells.
    Yu J; Li S; Qi J; Chen Z; Wu Y; Guo J; Wang K; Sun X; Zheng J
    Cell Death Dis; 2019 Feb; 10(3):193. PubMed ID: 30804337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lobaplatin suppresses proliferation and peritoneal metastasis of colorectal cancer in a preclinical model.
    Shan L; Bai B; Lv Y; Xie B; Huang X; Zhu H
    Biomed Pharmacother; 2018 Dec; 108():486-491. PubMed ID: 30243080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dillenia suffruticosa dichloromethane root extract induced apoptosis towards MDA-MB-231 triple-negative breast cancer cells.
    Foo JB; Saiful Yazan L; Tor YS; Wibowo A; Ismail N; Armania N; Cheah YK; Abdullah R
    J Ethnopharmacol; 2016 Jul; 187():195-204. PubMed ID: 27131434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Curcumin Analog PAC Is a Potential Solution for the Treatment of Triple-Negative Breast Cancer by Modulating the Gene Expression of DNA Repair Pathways.
    Almalki E; Al-Amri A; Alrashed R; Al-Zharani M; Semlali A
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galbanic acid: Induced antiproliferation in estrogen receptor-negative breast cancer cells and enhanced cellular redox state in the human dermal fibroblasts.
    Sajjadi M; Karimi E; Oskoueian E; Iranshahi M; Neamati A
    J Biochem Mol Toxicol; 2019 Nov; 33(11):e22402. PubMed ID: 31576639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper complex derived from S-benzyldithiocarbazate and 3-acetylcoumarin induced apoptosis in breast cancer cell.
    Foo JB; Low ML; Lim JH; Lor YZ; Zainol Abidin R; Eh Dam V; Abdul Rahman N; Beh CY; Chan LC; How CW; Tor YS; Saiful Yazan L
    Biometals; 2018 Aug; 31(4):505-515. PubMed ID: 29623473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical activity of lobaplatin as a single agent and in combination with taxanes for ovarian carcinoma cells.
    Sun X; Lou LG; Sui DH; Wu XH
    Asian Pac J Cancer Prev; 2014; 15(22):9939-43. PubMed ID: 25520132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.